These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4386706)

  • 1. The failure of diphenylhydantoin to influence the beta-adrenergic receptor of the heart.
    Raines A; Levitt B
    Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):435-41. PubMed ID: 4386706
    [No Abstract]   [Full Text] [Related]  

  • 2. Depression of cardiac sympathetic nerve activity by diphenylhydantoin.
    Gillis RA; McClellan JR; Sauer TS; Standaert FG
    J Pharmacol Exp Ther; 1971 Dec; 179(3):599-610. PubMed ID: 5138030
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of 1-(4-oxyphenyl)-2n-butylamino-ethanone hydrochloride (BON) on blood circulation. 3. Effect on the sympathetic nerve fibres of the heart and kidneys].
    Fedina L; Kovách AG; Huszár V
    Arzneimittelforschung; 1970 Nov; 20(11):Suppl 11a:1656+. PubMed ID: 4395290
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of beta-adrenergic receptor blockade on the blood pressure and heart rate changes induced by noradrenaline infusion and postinfusional hypotension.
    Mazurkiewicz IM
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):136-58. PubMed ID: 4384633
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacology of beta sympathetic blockade.
    Shanks RG
    Am J Cardiol; 1966 Sep; 18(3):308-16. PubMed ID: 4380735
    [No Abstract]   [Full Text] [Related]  

  • 6. Blockade of a sympathetic nervous system reflex by diphenylhydantoin.
    Raines A; Niner JM
    Neuropharmacology; 1975 Jan; 14(1):61-6. PubMed ID: 1153076
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of diphenylhydantoin on the response to accelerator nerve stimulation.
    Roberts J
    Proc Soc Exp Biol Med; 1970 May; 134(1):274-80. PubMed ID: 5423513
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of ouabain on the arrhythmic effect of catecholamines].
    Mukaoara K
    Nihon Yakurigaku Zasshi; 1970; 66(1):36-44. PubMed ID: 4393358
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of sympathetic nervous activity on the antiarrhythmic efficacy of diphenylhydantoin.
    Raines A; Levitt B; Standaert FG; Sohn YJ
    Eur J Pharmacol; 1970; 11(3):293-7. PubMed ID: 5477306
    [No Abstract]   [Full Text] [Related]  

  • 10. Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology.
    Hamilton TC; Parkes MW
    Arzneimittelforschung; 1977 Jul; 27(7):1410-7. PubMed ID: 20114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action and mechanism of action of catecholamines and their derivatives].
    Ariëns EJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):118-41. PubMed ID: 4385328
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of the sympathetic nervous system in atropine-induced tachycardia in conscious cats.
    Samonina GE; Hakumäki MO
    Scand J Clin Lab Invest; 1983 Sep; 43(5):389-92. PubMed ID: 6139871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of naloxone to reduce clonidine-induced changes in blood pressure, heart rate and sympathetic nerve firing in cats.
    Shropshire AT; Wendt RL
    J Pharmacol Exp Ther; 1983 Mar; 224(3):494-500. PubMed ID: 6827474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC; Kirchgessner T; Parmenter K
    J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental studies of the specificity and aspecificity of a beta-adrenolytic agent, bunitrolol (Kö 1366)].
    Marmo E; Lampa E; Rossi F; Caputi AP; Chieppa S; Vacca C; Giordano L; Pedone P
    Arch Sci Med (Torino); 1978; 135(1):15-56. PubMed ID: 25057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 17. Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine.
    Schmitt H; Fénard S
    Arzneimittelforschung; 1973 Jan; 23(1):40-5. PubMed ID: 4146793
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of ouabain and its interaction with diphenylhydantoin on cardiac arrhythmias induced by hypothalamic stimulation.
    Evans DE; Gillis RA
    J Pharmacol Exp Ther; 1975 Dec; 195(3):577-86. PubMed ID: 1195139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myocardial contractility and drug effects with special reference to the adrenergic mechanism].
    Otorii T; Imai S
    Nihon Rinsho; 1972 Oct; 30(10):2043-50. PubMed ID: 4405499
    [No Abstract]   [Full Text] [Related]  

  • 20. Adrenergic contribution to digitalis action.
    Tanabe T; Shudo I; Saito H
    Proc West Pharmacol Soc; 1975; 18():20-2. PubMed ID: 241087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.